Skip to main content
Back to Sequoia Capital

Sequoia Capital's Life Science Portfolio

Browse 5 Life Science companies funded by Sequoia Capital. See funding amounts, founder contacts, and investment details.

Life Science Companies
5
Total Funding in Life Science
$1.5B

Life Science Portfolio Companies (5)

Export
Artificial Intelligence (AI)Foundational AIHealth CareLife Science

Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design.

San Francisco, United States
July 2026
$400.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Palo Alto, United States
July 2026
$1.0B
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science

Athelas develops technology to monitor chronically ill patients in their homes.

Mountain View, United States
January 2022
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareLife Science

Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.

Pleasanton, United States
December 2021
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyConsumerHealth CareLife Science

Myome helps identify genes that cause disease and act based on leading science.

Palo Alto, United States
December 2025
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Explore Sequoia Capital's Full Portfolio

View all companies funded by Sequoia Capital across every industry and funding stage.

View Full Sequoia Capital Portfolio